Results 51 to 60 of about 265,644 (234)

Surgery in Autoimmune Pancreatitis

open access: yesDigestive Surgery, 2021
<b><i>Introduction:</i></b> Autoimmune pancreatitis (AIP) is a disease that may mimic malignant pancreatic lesions both in terms of symptomatology and imaging appearance. The aim of the present study is to analyze experiences of surgery in patients with AIP in one of the largest European cohorts.
Sara Nikolic   +9 more
openaire   +4 more sources

Mass-forming type 2 autoimmune pancreatitis with upstream dilatation of the main pancreatic duct dilatation: a case report

open access: yesJournal of Medical Case Reports
Background Type 2 autoimmune pancreatitis is characterized by multiple or segmental strictures of the main pancreatic duct without upstream dilatation.
Noriyuki Tagai   +3 more
doaj   +1 more source

Pancreatitis Can Present Like Cancer: Lymphoplasmacytic Sclerosing Pancreatitis in a Patient with a History of Gastric Carcinoma

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2019
Autoimmune pancreatitis has been associated with many syndromes in the presence of increased immunoglobulin levels. IgG4 antibodies are elevated in the context of lymphoplasmacytic sclerosing pancreatitis associated with IgG4-related disease.
Susana Rocha Amaral   +4 more
doaj   +1 more source

Autoimmune pancreatitis: Current perspectives

open access: yesIndian Journal of Pathology and Microbiology, 2021
Over the last two decades, our knowledge and understanding regarding the pathogenesis and biology of autoimmune pancreatitis (AIP) have improved tremendously.
Surbhi Goyal, Puja Sakhuja
doaj   +1 more source

Endosonographic features of autoimmune pancreatitis [PDF]

open access: yes, 2016
Autoimmune pancreatitis (AIP) has come to be increasingly recognized due to the evolving awareness about the disease and the possibility of making a correct diagnosis based on consensus diagnostic criteria.
窪田, 賢輔   +2 more
core  

Autoimmune Pancreatitis Type II: First Report from India [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Autoimmune Pancreatitis (AIP) presents in two forms - Type I or lymphoplasmacytic sclerosing pancreatitis and Type II or idiopathic ducto-centric pancreatitis (IDCP). AIP II is rare in south Asia and, especially so, in India.
Gunjan Desai   +3 more
doaj   +1 more source

Human biomarker navigator

open access: yesiMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

The dual role of endoscopic ultrasonography in the diagnosis and treatment of autoimmune pancreatitis with gastric variceal bleeding: A case report and literature review

open access: yesJournal of International Medical Research
Autoimmune pancreatitis is a rare type of chronic pancreatitis associated with immune disorders. Co-occurrence of regional portal hypertension and gastric variceal bleeding associated with autoimmune pancreatitis is exceedingly rare.
Wenfeng Xi   +5 more
doaj   +1 more source

An unusual case of autoimmune pancreatitis presenting as pancreatic mass and obstructive jaundice: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2011
Background Autoimmune pancreatitis is a rare chronic inflammatory pancreatic disease that is increasingly being diagnosed worldwide. As a result of overlap in clinical and radiological features, it is often misdiagnosed as pancreatic cancer.
Conley Barbara A   +6 more
doaj   +1 more source

Long‐Term Outcomes of Low‐Dose Steroid Induction for Autoimmune Pancreatitis: A Multicenter Retrospective Study Identifying Risk Factors for Relapse

open access: yesJournal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background Steroids are the first‐line treatment for autoimmune pancreatitis (AIP); however, the impact of lower initial doses on relapse remains unclear. Methods Ninety patients were divided into high‐dose (HD; > 0.4 mg/kg/day) and low‐dose (LD; ≤ 0.4 mg/kg/day) induction groups. The treatment response, relapse rate, and predictors of relapse
Yuhei Iwasa   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy